Pronota

About:

Pronota develops diagnostic devices for the early detection of conditions such as heart failure, pre-eclampsia and sepsis.

Website: http://www.pronota.com

Twitter/X: mycartis

Top Investors: EQT Life Sciences, Gimv, VIB, MP Healthcare Venture Management, Johnson & Johnson Development Corporation

Description:

Pronota NV is developing and commercialising first-in-class diagnostics for early detection of life-threatening conditions and unmet medical needs including heart failure, pre-eclampsia and sepsis. Pronota's non-invasive, validated, diagnostics are proprietary and focused on improving quality of care for patients. Backed by a solid base of investors including GIMV, LSP, KBC Private Equity and JJDC, and a wide network of renowned key opinion leaders, Pronota is committed to making a difference in diagnosis and personalized healthcare. Pronota NV was formerly known as Peakadilly NV and changed its name to Pronota NV in November 2006. The company was founded in 2004 and is based in Zwijnaarde, Belgium.